0.40
-0.0211(-5.00%)
Currency In USD
| Previous Close | 0.42 |
| Open | 0.45 |
| Day High | 0.45 |
| Day Low | 0.4 |
| 52-Week High | 1.92 |
| 52-Week Low | 0.38 |
| Volume | 320,851 |
| Average Volume | 529,887 |
| Market Cap | 79.6M |
| PE | -2.23 |
| EPS | -0.18 |
| Moving Average 50 Days | 0.58 |
| Moving Average 200 Days | 0.96 |
| Change | -0.02 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $40.3 as of December 07, 2025 at a share price of $0.401. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $36.29 as of December 07, 2025 at a share price of $0.401.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID
GlobeNewswire Inc.
Nov 05, 2025 8:20 PM GMT
T Cell Engaging Antigen Presenting Cell Human Leukocyte Antigens (HLA) show foreign protein to T cells. HLA varies from person to person. For this reason, a panel of T cells is necessary to match a variety of HLA types. This milestone expands pat
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
GlobeNewswire Inc.
Nov 03, 2025 7:45 PM GMT
Tevogen Bio Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today issued a statem
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
GlobeNewswire Inc.
Oct 29, 2025 4:35 PM GMT
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to underscore its biopharma model centered on sustainability